Marshall Wace North America Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Apple
AAPL
|
+$213M |
| 3 |
Elevance Health
ELV
|
+$188M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$183M |
| 2 |
AbbVie
ABBV
|
+$149M |
| 3 |
Humana
HUM
|
+$120M |
| 4 |
Fidelity National Information Services
FIS
|
+$119M |
| 5 |
Mercado Libre
MELI
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.33% |
| 2 | Technology | 17.93% |
| 3 | Consumer Discretionary | 11.98% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.6% |
Similar funds
Marshall Wace North America's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.
- Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
- Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
- Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
- Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
- Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
- Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
- Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.
Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.